|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 577 JPY | +0.52% |
|
+3.04% | -50.77% |
| 31/05 | JCR Pharmaceuticals' Full-Year Profit Up 46% | MT |
| 27/05 | Jefferies Adjusts JCR Pharmaceuticals’ Price Target to 560 Yen From 1,200 Yen, Keeps at Hold | MT |
JCR Pharmaceuticals Co., Ltd. appointed Yoh Ito as Senior Corporate Officer of the company, with effect from December 1, 2022.
| 1st Jan change | Capi. | |
|---|---|---|
| -50.77% | 46Cr | |
| +40.73% | 74TCr | |
| +32.83% | 60TCr | |
| -6.30% | 35TCr | |
| +15.15% | 32TCr | |
| +4.05% | 28TCr | |
| +15.00% | 24TCr | |
| +9.78% | 21TCr | |
| -5.52% | 21TCr | |
| +6.17% | 16TCr |
JCR PHARMACEUTICALS CO., LTD. 
